D&D Pharmatech Inc.
4Patents
4Active
4Granted
44Portfolio score
Filing activity: Mar 11, 2015 → Jul 19, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10406230B2 | Exendin-4 analogue pegylated with polyethylene glycol or derivative thereof, preparation method thereof, and pharmaceutical composition for preventing or treating diabetes, containing same as active ingredient | Chemistry; Metallurgy | 1 | Active |
| US11299528B2 | Long acting TRAIL receptor agonists for treatment of autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
| US10046059B2 | Methods of administering an N-terminal modified PEG-TRAIL | Physics | 0 | Active |
| US12338270B2 | Pharmaceutical composition comprising polypeptide | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.